Hims & Hers Health, Inc. (HIMS) concluded the recent trading session at $47.6, signifying a -5.52% move from its prior day's close.

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

TechCrunch Senior Reporter Rebecca Bellan breaks down Elon Musk’s latest move to bring Grok AI to Tesla vehicles and why the ...

Genmab A/S Sponsored ADR (GMAB) closed the last trading session at $21.69, gaining 4.9% over the past four weeks, but there ...

The BUZZ Index returned 12.68% during the month of June compared to a return of 5.09% for the S&P 500 Index during the same ...

AXT Inc (AXTI) is looking like an interesting pick from a technical perspective, as the company reached a key level of ...

Novo Nordisk sees 65% obesity drug sales growth, forecasts $8.14–$9.59B FY25 free cash flow. Click here to read an analysis ...

It isn't easy finding high-yield dividend growth stocks when the market is at an all-time high. Shares of Novo Nordisk and ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Philip Morris International Inc. (PM) ...

We can't have it both ways. If we want more cutting-edge drugs, we have to protect the property rights that make them ...

Microsoft has issued an urgent security alert this weekend after discovering attackers exploiting a critical zero‑day ...

Detailed price information for Meta Platforms Inc (META-Q) from The Globe and Mail including charting and trades.